Latest News

02.25.21

Remembering Ophthalmic Industry Executive George Marcellino

Source: Iridex

02.25.21

Moderna’s Variant-Specific COVID-19 Vaccine Candidate Ready for Clinical Testing

Source: FirstWord

02.25.21

Allergan Submits New Drug Application for Investigational Eye Drop for the Treatment of Presbyopia

Source: Allergan

02.24.21

New Survey Assessment Finds Debilitating Impact of Thyroid Eye Disease (TED) on Quality of Life Continues Beyond Acute Disease into Chronic Phase

Source: Horizon Therapeutics

02.24.21

One-Dose J&J COVID-19 Vaccine Meets Criteria as Safe and Effective, FDA Report Finds

Source: USA Today

02.24.21

International Team Identifies 127 Glaucoma Genes in Largest Study of Its Kind

Source: Massachusetts Eye and Ear

02.24.21

NeurOptics Launches Virtual Pupillometry Education Platform

Source: NeurOptics

02.24.21

VRmagic Eyesi Slit Lamp Fundoscopy Module Launched in the UK

Source: Haag-Streit UK

02.24.21

Pfizer, Moderna and J&J Tout Supercharged COVID-19 Vaccine Output, Eyeing Nearly 140 Million New Doses by March

Source: FiercePharma

02.23.21

FCI Ophthalmics Announces Availability of LacriJet for Monocanalicular Nasolacrimal Intubation

Source: FCI Ophthalmics

02.23.21

Lexitas Announces George N. Magrath, MD, MBA Assumes Role of Chief Executive Officer

Source: Lexitas

02.23.21

Topcon Announces US Launch of the Harmony Glaucoma Module

Source: Topcon

02.23.21

Bausch + Lomb Launches Alaway Preservative Free Antihistamine Eye Drops

Source: Bausch + Lomb

02.23.21

AcuFocus Submits US Premarket Approval Application to the FDA for Its IC-8 Small Aperture IOL

Source: AcuFocus

02.23.21

Optimo Medical and Ansys Partner Announce Partnership to Improve Surgery Preparation

Source: Optimo Medical

02.23.21

Allergan Launches Refresh Digital Lubricant Eye Drops

Source: Abbvie

View more stories